Multiplane L-Scar Augmentation Mastopexy: An Individualized Approach to Muscle, Glandular Tissue, and Skin

Abstract

Background: Augmentation mastopexy focuses on restoring the youthful appearance of the female breast. Despite those benefits, there is large scarring to be considered, and the reduction of this side effect is the main goal to enhance the aesthetic result. This article aims to describe a variation of the L-shaped mastopexy technique without complex marking and performed in planes, which improves long-term results for patients undergoing this approach. Methods: This is a retrospective, observational study, based on a series of cases conducted by the author. The preoperative appointment and the surgical technique are described and divided into steps according to their components: cutaneous, glandular tissue, and muscular. Results: Between January of 2016 and July of 2021, 632 women underwent surgery. The mean age was 38 years (range, 18 to 71 years). The mean volume of implants was 285 cc (range, 175 to 550 cc). All the implants used were round with a nanotextured surface. The mean amount of tissue resected from each breast was 117 g (range, 5 to 550 g). Follow-ups ranged from 12 to 84 months, and photographic documentation was performed from 30 days after surgery. Complications totaled 19.30% and were divided into minor [treated with expectant treatment, noninvasive, or with the possibility of correction with local anesthesia (10.44%)] and major [in which it was necessary to return to the operating room (8.86%)]. Conclusions: Multiplane L-scar mastopexy is a versatile and safe technique with predictable results, which allows the systematic treatment of the most diverse breast types, with complications similar to other already described and solidified techniques.

Discussion: Multiplane L-Scar Augmentation Mastopexy: An Individualized Approach to Muscle, Glandular Tissue, and Skin

“…Discussion: Multiplane L-Scar Augmentation Mastopexy: An Individualized Approach to Muscle, Glandular Tissue, and Skin Melinda J. Haws, MD Nashville, TN A s I review this article, I applaud the authors' documentation of 632 women who underwent multiplane L-scar augmentation mastopexy from January of 2016 to July of 2021, including a discussion of all complications and the need for revision. 1 Their follow-up time of 12 to 84 months is also critical, as we all know the true value of an augmentation mastopexy is its ability to withstand the test of time. I found the use of videos incredibly valuable to visualize several of the steps in their procedure.…”